Endogenous glutamine decrease is associated with pancreatic cancer progression.

about

Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.

P2860

Q49805542-76B648F9-1657-45EF-9F71-FD6199C6620A

P2860

Endogenous glutamine decrease is associated with pancreatic cancer progression.

Item

http://www.wikidata.org/entity/Q47095381

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Endogenous glutamine decrease is associated with pancreatic cancer progression.

@en

Endogenous glutamine decrease is associated with pancreatic cancer progression.

@nl

type

Item

label

Endogenous glutamine decrease is associated with pancreatic cancer progression.

@en

Endogenous glutamine decrease is associated with pancreatic cancer progression.

@nl

prefLabel

Endogenous glutamine decrease is associated with pancreatic cancer progression.

@en

Endogenous glutamine decrease is associated with pancreatic cancer progression.

@nl

P1476

Endogenous glutamine decrease is associated with pancreatic cancer progression

@en

P2093

Cecilia Roux

http://www.w3.org/2001/XMLSchema#string

Chiara Riganti

http://www.w3.org/2001/XMLSchema#string

Claudia Curcio

http://www.w3.org/2001/XMLSchema#string

Francesco Novelli

http://www.w3.org/2001/XMLSchema#string

Giuseppe Digilio

http://www.w3.org/2001/XMLSchema#string

Maria Paola Puccinelli

http://www.w3.org/2001/XMLSchema#string

Monica Isabello

http://www.w3.org/2001/XMLSchema#string

Roberta Curto

http://www.w3.org/2001/XMLSchema#string

Sammy Ferri Borgogno

http://www.w3.org/2001/XMLSchema#string

Sergio Padovan

http://www.w3.org/2001/XMLSchema#string

P2860

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function

Advances in pancreatic cancer research: moving towards early detection

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up

Dysregulated metabolism contributes to oncogenesis

Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters

The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.

From Krebs to clinic: glutamine metabolism to cancer therapy.

P304

95361-95376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20545

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paola Cappello

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29221133

http://www.w3.org/2001/XMLSchema#string

P932

5707027

http://www.w3.org/2001/XMLSchema#string

Endogenous glutamine decrease is associated with pancreatic cancer progression.

about

P2860

P2860

Endogenous glutamine decrease is associated with pancreatic cancer progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932